The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes

被引:45
作者
Filippov, Valery [1 ]
Filippova, Maria [1 ]
Duerksen-Hughes, Penelope J. [1 ]
机构
[1] Loma Linda Univ, Sch Med, Dept Biochem & Microbiol, Loma Linda, CA 92354 USA
关键词
D O I
10.1158/0008-5472.CAN-07-0145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expression of the human papillomavirus 16 E6 oncogene interferes with several vital cellular processes, including the p53-dependent response to DNA damage. To assess the influence of E6 on the early response to DNA damage, we analyzed gene expression following mitomycin C-induced genotoxic stress in human E6-expressing U20S cells (U20SE64b) as well as in p53-expressing control cells (U20SE6AS) by comparative global expression profiling. As expected, genes involved in p53-dependent pathways were activated in p53-expressing cells. In the U20SE64b cells, however, a largely nonoverlapping group of genes was identified, including two splicing factors of the SR family. Immunoblot analysis revealed increased expression of several SR proteins during the early response to DNA damage, which was accompanied by activation of alternative splicing activity. Disruption of splicing activity by treatment with small interfering RNA directed against splicing factor SRp55 resulted in the increased viability of p53-deficient cells following DNA damage. To determine whether the transient activation of splicing activity was due to E6-mediated degradation of p53, or was due to some other activity of E6, we compared the early response of the p53 wild-type and p53-/- isogenic HCT116 cell lines, and found that the increase in splicing activity was observed only in the absence of p53. Finally, both the U20SE64b and the p53-/- cells showed altered splicing patterns for the CD44 receptor. Together, these data show that cells lacking p53 can activate alternative splicing following DNA damage.
引用
收藏
页码:7621 / 7630
页数:10
相关论文
共 42 条
[31]   Cell signalling and the control of pre-mRNA splicing [J].
Shin, C ;
Manley, JL .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (09) :727-738
[32]   TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity [J].
Tomasini, R ;
Samir, AA ;
Carrier, A ;
Isnardon, D ;
Cecchinelli, B ;
Soddu, S ;
Malissen, B ;
Dagorn, JC ;
Iovanna, JL ;
Dusetti, NJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37722-37729
[33]   The role of TP53 in cervical carcinogenesis [J].
Tommasino, M ;
Accardi, R ;
Caldeira, S ;
Dong, W ;
Malanchi, E ;
Smet, A ;
Zehbe, I .
HUMAN MUTATION, 2003, 21 (03) :307-312
[34]   Stress-induced aberrant splicing of TSG101:: association to high tumor grade and p53 status in breast cancers [J].
Turpin, E ;
Dalle, B ;
de Roquancourt, A ;
Plassa, LF ;
Marty, M ;
Janin, A ;
Beuzard, Y ;
de Thé, H .
ONCOGENE, 1999, 18 (54) :7834-7837
[35]   Aberrant and alternative splicing in cancer [J].
Venables, JP .
CANCER RESEARCH, 2004, 64 (21) :7647-7654
[36]  
VERJEIJ M, 1996, NATURE, V380, P75
[37]   p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa [J].
Villunger, A ;
Michalak, EM ;
Coultas, L ;
Müllauer, F ;
Böck, G ;
Ausserlechner, MJ ;
Adams, JM ;
Strasser, A .
SCIENCE, 2003, 302 (5647) :1036-1038
[38]   Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes [J].
Willis, A ;
Jung, EJ ;
Wakefield, T ;
Chen, XB .
ONCOGENE, 2004, 23 (13) :2330-2338
[39]   A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10 [J].
Yu, QM ;
Guo, J ;
Zhou, JH .
JOURNAL OF NEUROCHEMISTRY, 2004, 90 (01) :164-172
[40]   Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53 [J].
Zhang, C ;
Gao, CF ;
Kawauchi, J ;
Hashimoto, Y ;
Tsuchida, N ;
Kitajima, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 297 (05) :1302-1310